Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News BioVie Inc BIVI

BioVie Inc. is a clinical-stage company engaged in developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company’s drug candidate NE3107 inhibits inflammatory activation of extracellular single-regulated kinase (ERK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) that... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:BIVI)

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer's Disease and Biomarker Endpoints

GlobeNewswire 23 hours ago

BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

GlobeNewswire 7 days ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire 13 days ago

Lawsuit Notice: Investors who lost money with BioVie Inc. (NASDAQ: BIVI) shares should contact the Shareholders Foundation

PR Newswire March 26, 2024

Levi & Korsinsky Reminds BioVie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - BIVI

Accesswire March 19, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines - BIVI

PR Newswire March 19, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioVie Inc.(BIVI) Shareholders

Accesswire March 19, 2024

DEADLINE TODAY: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm

Newsfile March 19, 2024

Class Action Filed Against BioVie Inc. (BIVI) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire March 19, 2024

Opinion & Analysis (NDAQ:BIVI)

No current opinion is available.

Bullboard Posts (NDAQ:BIVI)

Genetic Technologies and BioVie Interviews to Air on the Red

BREAKING NEWS: $BIVI Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg...
whytestocks - 13 days ago

Why BioVie (BIVI) Shares Are Down 40% | Benzinga

BREAKING NEWS: $BIVI Why BioVie (BIVI) Shares Are Down 40% | BenzingaBioVie Inc (NASDAQ:BIVI) shares are trading lower by 42% to $1.09...
whytestocks - March 4, 2024

US Stocks Mixed; Dell Posts Upbeat Results | Benzinga

BREAKING NEWS: $BIVI US Stocks Mixed; Dell Posts Upbeat Results | BenzingaU.S. stocks traded mixed this morning, with the Dow Jones...
whytestocks - March 1, 2024

BIOVIE INC. SECURITIES FRAUD NOTICE: Berger Montague Informs

JUST IN: $BIVI BIOVIE INC. SECURITIES FRAUD NOTICE: Berger Montague Informs BioVie Inc. (BIVI) Investors of Securities Fraud...
whytestocks - February 21, 2024

STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against

BREAKING NEWS: $BIVI STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against BioVie Inc. (BIVI)Philadelphia, Pennsylvania--(Newsfile...
whytestocks - February 9, 2024

BIOVIE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securi

News; $BIVI BIOVIE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages...
whytestocks - February 2, 2024